| Acute Leukemia of Ambiguous Lineage studied in …STUDIED_INderived139 of 139show fewer |
|---|
| → studied in | NCT03779854Phase 2 · active not recruiting Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant · condition mapped CURATED_BROADER · 139 trials mapped (66 active) | — | — | Acute Leukemia of Ambiguous Lineage | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06317662Phase 2 · recruiting Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia · condition mapped CURATED_BROADER · 139 trials mapped (66 active) | — | — | Acute Leukemia of Ambiguous Lineage | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07346105available Orca-T Expanded Access Program Study for Patients With Advanced Hematologic Malignancies · condition mapped ONTOLOGY_EXACT · 139 trials mapped (66 active) | — | — | Mixed Phenotype Acute Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04375631Phase 1 · recruiting CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia · condition mapped CURATED_BROADER · 139 trials mapped (66 active) | — | — | Acute Leukemia of Ambiguous Lineage | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07094750NA · recruiting Randomization for the Identification of Best Treatment Intensity for Less Fit Adults With Acute Myeloid Leukemia and Myeloid Neoplasms · condition mapped CURATED_BROADER · 139 trials mapped (66 active) | — | — | Acute Leukemia of Ambiguous Lineage | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04065399Phase 1/Phase 2 · recruiting A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation · condition mapped CURATED_BROADER · 139 trials mapped (66 active) | — | — | Acute Leukemia of Ambiguous Lineage | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03683433Phase 2 · recruiting Enasidenib and Azacitidine in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia and IDH2 Gene Mutation · condition mapped ONTOLOGY_EXACT · 139 trials mapped (66 active) | — | — | Acute Bilineal Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04128501Phase 2 · active not recruiting Venetoclax and Azacitidine for the Treatment of Acute Myeloid Leukemia in the Post-Transplant Setting · condition mapped ONTOLOGY_EXACT · 139 trials mapped (66 active) | — | — | Acute Bilineal Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07819396Phase 2 · not yet recruiting Depletion of CD45RA Positive Naive T Cells for the Prevention of Graft Versus Host Disease in Older Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Acute Leukemia or Myelodysplastic Syndrome · condition mapped CURATED_BROADER · 139 trials mapped (66 active) | — | — | Acute Leukemia of Ambiguous Lineage | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05589896Phase 1/Phase 2 · active not recruiting A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies · condition mapped ONTOLOGY_EXACT · 139 trials mapped (66 active) | — | — | Acute Biphenotypic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07710781NA · not yet recruiting Study to Characterize Mismatched to Fully HLA-Matched Ossium HPC, Marrow and Living Donor Transplantation in Patients With Hematologic Malignancies · condition mapped ONTOLOGY_EXACT · 139 trials mapped (66 active) | — | — | Acute Biphenotypic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05322850Phase 1/Phase 2 · recruiting Phase I/II Trial: Engineered Donor Graft (Orca Q) for Pediatric Hematopoietic Cell Transplant (HCT) · condition mapped ONTOLOGY_EXACT · 139 trials mapped (66 active) | — | — | Mixed Phenotype Acute Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02159495Phase 1 · active not recruiting Genetically Modified T-cell Immunotherapy in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia and Persistent/Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm · condition mapped ONTOLOGY_EXACT · 139 trials mapped (66 active) | — | — | Acute Biphenotypic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03959085Phase 3 · recruiting Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy · condition mapped ONTOLOGY_EXACT · 139 trials mapped (66 active) | — | — | Mixed Phenotype Acute Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04726241Phase 1/Phase 2 · recruiting The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study · condition mapped ONTOLOGY_EXACT · 139 trials mapped (66 active) | — | — | Mixed Phenotype Acute Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05761171Phase 2 · active not recruiting A Study of Revumenib in Combination With Chemotherapy for Patients Diagnosed With Relapsed or Refractory Leukemia · condition mapped CURATED_BROADER · 139 trials mapped (66 active) | — | — | Acute Leukemia of Ambiguous Lineage | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05602194Phase 3 · active not recruiting Studying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for Leukemia or Lymphoma · condition mapped ONTOLOGY_EXACT · 139 trials mapped (66 active) | — | — | Mixed Phenotype Acute Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02879695Phase 1 · active not recruiting Blinatumomab and Nivolumab With or Without Ipilimumab in Treating Patients With Poor-Risk Relapsed or Refractory CD19+ Precursor B-Lymphoblastic Leukemia · condition mapped CURATED_BROADER · 139 trials mapped (66 active) | — | — | Mixed Phenotype Acute Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03007147Phase 3 · active not recruiting Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia · condition mapped ONTOLOGY_EXACT · 139 trials mapped (66 active) | — | — | Mixed Phenotype Acute Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06390319Phase 2 · recruiting Adding Dasatinib Or Venetoclax To Improve Responses In Children With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (ALL) Or Lymphoma (T-LLY) Or Mixed Phenotype Acute Leukemia (MPAL) · condition mapped ONTOLOGY_EXACT · 139 trials mapped (66 active) | — | — | Mixed Phenotype Acute Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06533579Phase 1/Phase 2 · recruiting Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19) · condition mapped ONTOLOGY_EXACT · 139 trials mapped (66 active) | — | — | Mixed Phenotype Acute Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06177067Phase 1 · recruiting Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia · condition mapped CURATED_BROADER · 139 trials mapped (66 active) | — | — | Acute Leukemia of Ambiguous Lineage | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02727803Phase 2 · recruiting Personalized NK Cell Therapy in CBT · condition mapped ONTOLOGY_EXACT · 139 trials mapped (66 active) | — | — | Acute Biphenotypic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04975919Phase 2 · active not recruiting Venetoclax in Combination With Decitabine and Cedazuridine for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia · condition mapped CURATED_BROADER · 139 trials mapped (66 active) | — | — | Acute Biphenotypic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05457556Phase 3 · active not recruiting Mismatched Related Donor Versus Matched Unrelated Donor Stem Cell Transplantation for Children, Adolescents, and Young Adults With Acute Leukemia or Myelodysplastic Syndrome · condition mapped ONTOLOGY_EXACT · 139 trials mapped (66 active) | — | — | Mixed Phenotype Acute Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06034470Phase 1 · active not recruiting Combination Chemotherapy (FLAG-Ida) With Pivekimab Sunirine (PVEK) for the Treatment of Newly Diagnosed Adverse Risk Acute Myeloid Leukemia and Other High-Grade Myeloid Neoplasms · condition mapped ONTOLOGY_EXACT · 139 trials mapped (66 active) | — | — | Mixed Phenotype Acute Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06013423Phase 2 · recruiting Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases · condition mapped CURATED_BROADER · 139 trials mapped (66 active) | — | — | Acute Leukemia of Ambiguous Lineage | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07046078Phase 2 · recruiting Combination Chemotherapy (FLAG-Ida) Followed Immediately by Reduced-Intensity Total Body Radiation Therapy and Donor Hematopoietic Cell Transplant for the Treatment of Adults Age 60 and Older With Newly Diagnosed Adverse-Risk Acute Myeloid Leukemia or Other High-Grade Myeloid Cancer · condition mapped CURATED_BROADER · 139 trials mapped (66 active) | — | — | Acute Leukemia of Ambiguous Lineage | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03843528Phase 1 · active not recruiting Vorinostat Dose-escalation After Allogeneic Hematopoietic Cell Transplantation · condition mapped ONTOLOGY_EXACT · 139 trials mapped (66 active) | — | — | Mixed Phenotype Acute Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06289673Phase 4 · recruiting Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma · condition mapped ONTOLOGY_EXACT · 139 trials mapped (66 active) | — | — | Mixed Phenotype Acute Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07254793Phase 1 · not yet recruiting Prophylactic and Therapeutic DLI-X for Leukemia Relapse After HCT · condition mapped ONTOLOGY_EXACT · 139 trials mapped (66 active) | — | — | Acute Undifferentiated Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03399773Phase 2 · active not recruiting Infusion of Expanded Cord Blood Cells in Addition to Single Cord Blood Transplant in Treating Patients With Acute Leukemia, Chronic Myeloid Leukemia, or Myelodysplastic Syndromes · condition mapped ONTOLOGY_EXACT · 139 trials mapped (66 active) | — | — | Acute Biphenotypic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05327894Phase 3 · recruiting Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia · condition mapped ONTOLOGY_EXACT · 139 trials mapped (66 active) | — | — | Mixed Phenotype Acute Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07216443Phase 2 · recruiting Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome · condition mapped ONTOLOGY_EXACT · 139 trials mapped (66 active) | — | — | Mixed Phenotype Acute Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03802695Phase 1 · recruiting A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies · condition mapped ONTOLOGY_EXACT · 139 trials mapped (66 active) | — | — | Mixed Phenotype Acute Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06551584Phase 1 · recruiting Trial for Patients w/ Advanced Hematologic Malignancies Undergoing Allogeneic HCT · condition mapped ONTOLOGY_EXACT · 139 trials mapped (66 active) | — | — | Mixed Phenotype Acute Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03128034Phase 1/Phase 2 · recruiting 211^At-BC8-B10 Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, or Mixed-Phenotype Acute Leukemia · condition mapped CURATED_BROADER · 139 trials mapped (66 active) | — | — | Mixed Phenotype Acute Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03670966Phase 1/Phase 2 · recruiting 211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome · condition mapped CURATED_BROADER · 139 trials mapped (66 active) | — | — | Mixed Phenotype Acute Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07356154Phase 1/Phase 2 · recruiting A Study of Revumenib and Mezigdomide in People With Leukemia · condition mapped ONTOLOGY_EXACT · 139 trials mapped (66 active) | — | — | Mixed Phenotype Acute Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04047641Phase 1/Phase 2 · recruiting Cladribine, Idarubicin, Cytarabine, and Quizartinib in Treating Patients With Newly Diagnosed, Relapsed, or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome · condition mapped CURATED_BROADER · 139 trials mapped (66 active) | — | — | Acute Biphenotypic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07636564Phase 2 · not yet recruiting Testing Blinatumomab With or Without Revumenib in Patients With B-cell Acute Lymphoblastic Leukemia With a Genetic Change Requiring More Treatment · condition mapped CURATED_BROADER · 139 trials mapped (66 active) | — | — | Acute Leukemia of Ambiguous Lineage | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05146739Phase 1 · active not recruiting Highest Dose of Uproleselan in Combination With Fludarabine and Cytarabine for Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Mixed Phenotype Acute Leukemia Relapsed or Refractory That Expresses E-selectin Ligand on the Cell Membrane · condition mapped CURATED_BROADER · 139 trials mapped (66 active) | — | — | Mixed Phenotype Acute Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02220985Phase 2 · completed Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts From HLA-Matched Related and Unrelated Donors in Preventing GVHD · condition mapped CURATED_BROADER · 139 trials mapped (66 active) | — | — | Acute Leukemia of Ambiguous Lineage | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04195633Phase 2 · recruiting Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies · condition mapped ONTOLOGY_EXACT · 139 trials mapped (66 active) | — | — | Mixed Phenotype Acute Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02115295Phase 2 · recruiting Cladribine, Idarubicin, Cytarabine, and Venetoclax in Treating Patients With Acute Myeloid Leukemia, High-Risk Myelodysplastic Syndrome, or Blastic Phase Chronic Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 139 trials mapped (66 active) | — | — | Acute Biphenotypic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03326921Phase 1 · recruiting HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant · condition mapped CURATED_BROADER · 139 trials mapped (66 active) | — | — | Acute Biphenotypic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06928662Phase 1/Phase 2 · recruiting Chemotherapy (Decitabine in Combination With FLAG-Ida) and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Adults With Myeloid Malignancies at High Risk of Relapse · condition mapped ONTOLOGY_EXACT · 139 trials mapped (66 active) | — | — | Acute Undifferentiated Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04067336Phase 1/Phase 2 · active not recruiting First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia · condition mapped CURATED_BROADER · 139 trials mapped (66 active) | — | — | Acute Leukemia of Ambiguous Lineage | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07573670Phase 2 · not yet recruiting A Phase 2 Study of Bcl-2 Inhibitor Combined With Azacitidine for Newly Diagnosed Mixed Phenotype Acute Leukemia · condition mapped CURATED_BROADER · 139 trials mapped (66 active) | — | — | Mixed Phenotype Acute Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04872790Phase 1 · active not recruiting Venetoclax, Dasatinib, Prednisone, Rituximab and Blinatumomab for the Treatment of Newly Diagnosed or Relapsed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia or Mixed Phenotype Acute Leukemia · condition mapped ONTOLOGY_EXACT · 139 trials mapped (66 active) | — | — | Mixed Phenotype Acute Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07498465Phase 1 · withdrawn A Study to Find the Highest Dose of SNDX-5613 (Revumenib) as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, and Mixed Phenotype Acute Leukemia · condition mapped ONTOLOGY_EXACT · 139 trials mapped (66 active) | — | — | Childhood Mixed Phenotype Acute Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04898894Phase 1 · active not recruiting Study of Selinexor and Venetoclax in Combination With Chemotherapy in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia · condition mapped CURATED_BROADER · 139 trials mapped (66 active) | — | — | Acute Leukemia of Ambiguous Lineage | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04797767Phase 1/Phase 2 · recruiting Venetoclax and CLAG-M for the Treatment of Acute Myeloid Leukemia and High-Grade Myeloid Neoplasms · condition mapped ONTOLOGY_EXACT · 139 trials mapped (66 active) | — | — | Acute Biphenotypic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07222579Phase 2 · recruiting Subcutaneous Blinatumomab for Treatment of Adult Patients With CD19-Positive Mixed Phenotype Acute Leukemia (MPAL) · condition mapped ONTOLOGY_EXACT · 139 trials mapped (66 active) | — | — | Mixed Phenotype Acute Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07517510Phase 2 · enrolling by invitation HVA in the Treatment of Mixed-Phenotype Acute Leukemia(MPAL). · condition mapped CURATED_BROADER · 139 trials mapped (66 active) | — | — | Mixed Phenotype Acute Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04980404Phase 1 · active not recruiting Inqovi Maintenance Therapy in Myeloid Neoplasms · condition mapped ALIAS · 139 trials mapped (66 active) | — | — | Acute Undifferentiated Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04904588Phase 2 · active not recruiting HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide · condition mapped ONTOLOGY_EXACT · 139 trials mapped (66 active) | — | — | Mixed Phenotype Acute Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05292664Phase 1 · recruiting Venetoclax Basket Trial for High Risk Hematologic Malignancies · condition mapped CURATED_BROADER · 139 trials mapped (66 active) | — | — | Acute Leukemia of Ambiguous Lineage | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03404193Phase 2 · terminated Venetoclax and Decitabine in Treating Participants With Relapsed/Refractory Acute Myeloid Leukemia or Relapsed High-Risk Myelodysplastic Syndrome · condition mapped ONTOLOGY_EXACT · 139 trials mapped (66 active) | — | — | Mixed Phenotype Acute Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06575296Phase 1 · recruiting Revumenib for the Treatment of Acute Leukemia in Patients Post-Allogeneic Stem Cell Transplant · condition mapped CURATED_BROADER · 139 trials mapped (66 active) | — | — | Acute Leukemia of Ambiguous Lineage | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05316701Phase 3 · active not recruiting Precision-T: A Randomized Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies · condition mapped ONTOLOGY_EXACT · 139 trials mapped (66 active) | — | — | Mixed Phenotype Acute Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05170828Phase 1 · withdrawn Cryopreserved MMUD BM With PTCy for Hematologic Malignancies · condition mapped ONTOLOGY_EXACT · 139 trials mapped (66 active) | — | — | Acute Biphenotypic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06991920NA · not yet recruiting Immune-targeted Combination With Chemotherapy for Acute Leukemia of Ambiguous Lineage · condition mapped ALIAS · 139 trials mapped (66 active) | — | — | Mixed Phenotype Acute Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01199562active not recruiting Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant · condition mapped ONTOLOGY_EXACT · 139 trials mapped (66 active) | — | — | Acute Undifferentiated Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04872478Phase 1 · recruiting Pharmacokinetic and Safety Study of MRX-2843 in Adolescents and Adults With Relapsed/Refractory AML, ALL, or MPAL · condition mapped ONTOLOGY_EXACT · 139 trials mapped (66 active) | — | — | Mixed Phenotype Acute Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05901974Phase 2 · recruiting Venetoclax Combined With Azactidine in the Treatment of ALAL · condition mapped CURATED_BROADER · 139 trials mapped (66 active) | — | — | Acute Leukemia of Ambiguous Lineage | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07256210Phase 2 · recruiting Feasibility and Safety of Donor-derived NK-cell Infusions for Leukemia Relapse Prophylaxis After Hematopoietic Stem Cell Transplantation · condition mapped ONTOLOGY_EXACT · 139 trials mapped (66 active) | — | — | Mixed Phenotype Acute Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04874194Phase 1/Phase 2 · terminated Omacetaxine and Venetoclax for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome Harboring Mutant RUNX1 · condition mapped CURATED_BROADER · 139 trials mapped (66 active) | — | — | Acute Biphenotypic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04501614Phase 1/Phase 2 · terminated A Study of Ponatinib With Chemotherapy in Children, Teenagers, and Adults With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia · condition mapped ALIAS · 139 trials mapped (66 active) | — | — | Mixed Phenotype Acute Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02793544Phase 2 · completed HLA-Mismatched Unrelated Donor Bone Marrow Transplantation With Post-Transplantation Cyclophosphamide · condition mapped ONTOLOGY_EXACT · 139 trials mapped (66 active) | — | — | Acute Biphenotypic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03957915early Phase 1 · completed Study of Escalating Doses of INA03 Administered Intravenously as Single Agent in Adult Patients With Relapse/Refractory Acute Leukemia · condition mapped ONTOLOGY_EXACT · 139 trials mapped (66 active) | — | — | Mixed Phenotype Acute Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04440267Phase 2 · recruiting Efficacy of Acute Lymphoblastic Leukemia-Based Therapy in Treating Patients With Acute Leukemia of Ambiguous Lineage · condition mapped CURATED_BROADER · 139 trials mapped (66 active) | — | — | Acute Leukemia of Ambiguous Lineage | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04827745Phase 2 · completed Blinatumomab for Treatment of R/R or MRD-positive CD19-Positive MPAL · condition mapped ONTOLOGY_EXACT · 139 trials mapped (66 active) | — | — | Mixed Phenotype Acute Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05521087Phase 1 · withdrawn A Study of JNJ-75276617 in Combination With Conventional Chemotherapy for Pediatric and Young Adult Participants With Relapsed/Refractory Acute Leukemias · condition mapped CURATED_BROADER · 139 trials mapped (66 active) | — | — | Acute Leukemia of Ambiguous Lineage | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07012447Phase 2 · recruiting Venetoclax + Azacytidine for Newly Diagnosed ETP-like ALL and T-ALL With Myeloid Mutations · condition mapped ONTOLOGY_EXACT · 139 trials mapped (66 active) | — | — | Mixed Phenotype Acute Leukemia, T/Myeloid | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02397720Phase 2 · completed Nivolumab and Azacitidine With or Without Ipilimumab in Treating Patients With Refractory/Relapsed or Newly Diagnosed Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 139 trials mapped (66 active) | — | — | Acute Bilineal Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06355583Phase 2 · recruiting Intestinal Microbiota Transplant Prior to Allogeneic Stem Cell Transplant (MAST) Trial · condition mapped CURATED_BROADER · 139 trials mapped (66 active) | — | — | Acute Leukemia of Ambiguous Lineage | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00719888Phase 2 · completed Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With Hematologic Disease · condition mapped ONTOLOGY_EXACT · 139 trials mapped (66 active) | — | — | Acute Biphenotypic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02828358Phase 2 · completed Azacitidine and Combination Chemotherapy in Treating Infants With Acute Lymphoblastic Leukemia and KMT2A Gene Rearrangement · condition mapped CURATED_BROADER · 139 trials mapped (66 active) | — | — | Acute Leukemia of Ambiguous Lineage | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04526795Phase 1 · terminated Fludarabine, Cytarabine, and Pegcrisantaspase for the Treament of Relapsed or Refractory Leukemia · condition mapped CURATED_BROADER · 139 trials mapped (66 active) | — | — | Acute Biphenotypic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05476770Phase 1 · recruiting Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies · condition mapped ONTOLOGY_EXACT · 139 trials mapped (66 active) | — | — | Mixed Phenotype Acute Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05326516Phase 1 · completed A Study of Revumenib in Combination With Chemotherapy in Participants With R/R Acute Leukemia · condition mapped ONTOLOGY_EXACT · 139 trials mapped (66 active) | — | — | Mixed Phenotype Acute Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03198234Phase 1 · terminated Use of T-allo10 in Hematopoietic Stem Cell Transplantation (HSCT) for Blood Disorders · condition mapped ONTOLOGY_EXACT · 139 trials mapped (66 active) | — | — | Mixed Phenotype Acute Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00557193Phase 3 · completed Combination Chemotherapy With or Without Lestaurtinib in Treating Younger Patients With Newly Diagnosed Acute Lymphoblastic Leukemia · condition mapped ONTOLOGY_EXACT · 139 trials mapped (66 active) | — | — | Acute Undifferentiated Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05433532Phase 2 · completed Study of Azacitidine，Venetoclax，and Flumatinib in Newly Diagnosed Ph-positive Acute Leukemia and CML-AP/BP Patients · condition mapped ONTOLOGY_EXACT · 139 trials mapped (66 active) | — | — | Mixed Phenotype Acute Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02135874Phase 2 · completed Clofarabine, Idarubicin, Cytarabine, Vincristine Sulfate, and Dexamethasone in Treating Patients With Newly Diagnosed or Relapsed Mixed Phenotype Acute Leukemia · condition mapped CURATED_BROADER · 139 trials mapped (66 active) | — | — | Acute Leukemia of Ambiguous Lineage | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01858740Phase 2 · completed Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts in Preventing GVHD in Children · condition mapped CURATED_BROADER · 139 trials mapped (66 active) | — | — | Acute Leukemia of Ambiguous Lineage | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03096782Phase 2 · completed Umbilical Cord Blood Transplant With Added Sugar and Chemotherapy and Radiation Therapy in Treating Patients With Leukemia or Lymphoma · condition mapped ONTOLOGY_EXACT · 139 trials mapped (66 active) | — | — | Acute Biphenotypic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01951885Phase 3 · completed Tac, Mini-MTX, MMF Versus Tac, MTX for GVHD Prevention · condition mapped ONTOLOGY_EXACT · 139 trials mapped (66 active) | — | — | Acute Biphenotypic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05320380Phase 1/Phase 2 · withdrawn A Study of the Drug IMGN632 in Children With Leukemia That Has Come Back After Treatment or is Difficult to Treat · condition mapped CURATED_BROADER · 139 trials mapped (66 active) | — | — | Mixed Phenotype Acute Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03267186Phase 2 · completed Ibrutinib in Preventing Acute Leukemia in Patients After Reduced-Intensity Conditioning and Stem Cell Transplant · condition mapped ONTOLOGY_EXACT · 139 trials mapped (66 active) | — | — | Acute Biphenotypic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02728050Phase 1/Phase 2 · completed Filgrastim, Cladribine, Cytarabine, and Mitoxantrone With Sorafenib in Treating Patients With Newly-Diagnosed, Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome · condition mapped ONTOLOGY_EXACT · 139 trials mapped (66 active) | — | — | Acute Biphenotypic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01925131Phase 1 · completed S1312, Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Leukemia · condition mapped CURATED_BROADER · 139 trials mapped (66 active) | — | — | Acute Leukemia of Ambiguous Lineage | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00796068Phase 2 · completed Treosulfan, Fludarabine Phosphate, and Total-Body Irradiation in Treating Patients With Hematological Cancer Who Are Undergoing Umbilical Cord Blood Transplant · condition mapped ONTOLOGY_EXACT · 139 trials mapped (66 active) | — | — | Acute Biphenotypic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01028716Phase 2 · terminated Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies · condition mapped ONTOLOGY_EXACT · 139 trials mapped (66 active) | — | — | Acute Biphenotypic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02529813Phase 1 · completed CD19-Specific T-cells in Treating Patients With Advanced Lymphoid Malignancies · condition mapped ONTOLOGY_EXACT · 139 trials mapped (66 active) | — | — | Acute Biphenotypic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02551718NA · completed High Throughput Drug Sensitivity Assay and Genomics- Guided Treatment of Patients With Relapsed or Refractory Acute Leukemia · condition mapped CURATED_BROADER · 139 trials mapped (66 active) | — | — | Acute Leukemia of Ambiguous Lineage | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00061945Phase 1/Phase 2 · completed Alemtuzumab and Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia · condition mapped ONTOLOGY_EXACT · 139 trials mapped (66 active) | — | — | Acute Undifferentiated Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03012672Phase 2 · completed Higher or Lower Dose Cladribine, Cytarabine, and Mitoxantrone in Treating Medically Less Fit Patients With Newly Diagnosed Acute Myeloid Leukemia or Myeloid Neoplasm · condition mapped CURATED_BROADER · 139 trials mapped (66 active) | — | — | Acute Leukemia of Ambiguous Lineage | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04044560Phase 2 · terminated Blinatumomab for MRD in Pre-B ALL Patients Following Stem Cell Transplant · condition mapped ALIAS · 139 trials mapped (66 active) | — | — | Acute Undifferentiated Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05066958Phase 1/Phase 2 · unknown Ex-vivo Primed Memory Donor Lymphocyte Infusion to Boost Anti-viral Immunity After T-cell Depleted HSCT · condition mapped CURATED_BROADER · 139 trials mapped (66 active) | — | — | Acute Biphenotypic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03887156Phase 2/Phase 3 · unknown Evaluation of a Donor Testing Kit for the Prediction of AGVHD in Patient Receiving a Peripheral Blood Stem Cell Allograft · condition mapped CURATED_BROADER · 139 trials mapped (66 active) | — | — | Acute Biphenotypic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03825887Phase 3 · completed Nalbuphine Versus Morphine for Mucositis Pain in Pediatric Cancer Patients · condition mapped ALIAS · 139 trials mapped (66 active) | — | — | Acute Undifferentiated Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01690520Phase 2 · completed Donor Umbilical Cord Blood Transplant With or Without Ex-vivo Expanded Cord Blood Progenitor Cells in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, or Myelodysplastic Syndromes · condition mapped ONTOLOGY_EXACT · 139 trials mapped (66 active) | — | — | Acute Biphenotypic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04762485Phase 1/Phase 2 · unknown Humanized CD7 CAR T-cell Therapy for r/r CD7+ Acute Leukemia · condition mapped ONTOLOGY_EXACT · 139 trials mapped (66 active) | — | — | Mixed Phenotype Acute Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03739606Phase 2 · withdrawn Flotetuzumab in Treating Patients With Recurrent or Refractory CD123 Positive Blood Cancer · condition mapped ONTOLOGY_EXACT · 139 trials mapped (66 active) | — | — | Acute Biphenotypic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01371656Phase 3 · completed Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation · condition mapped CURATED_BROADER · 139 trials mapped (66 active) | — | — | Acute Leukemia of Ambiguous Lineage | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03807063Phase 1 · withdrawn Rivogenlecleucel Donor Lymphocyte Immunotherapy in Treating Patients With Recurrent Blood Cancers After Stem Cell Transplant · condition mapped ONTOLOGY_EXACT · 139 trials mapped (66 active) | — | — | Acute Bilineal Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01869777NA · completed Bioelectrical Impedance Measurement for Predicting Treatment Outcome in Patients With Newly Diagnosed Acute Leukemia · condition mapped ONTOLOGY_EXACT · 139 trials mapped (66 active) | — | — | Acute Undifferentiated Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02212561Phase 1 · completed Selinexor With Fludarabine and Cytarabine for Treatment of Refractory or Relapsed Leukemia or Myelodysplastic Syndrome · condition mapped ONTOLOGY_EXACT · 139 trials mapped (66 active) | — | — | Mixed Phenotype Acute Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02921061Phase 1/Phase 2 · completed Decitabine With GCLAM for Adults With Newly Diagnosed, Relapsed, or Refractory AML or High-Risk MDS · condition mapped ONTOLOGY_EXACT · 139 trials mapped (66 active) | — | — | Mixed Phenotype Acute Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01619761Phase 1 · unknown NK Cells in Cord Blood Transplantation · condition mapped ONTOLOGY_EXACT · 139 trials mapped (66 active) | — | — | Acute Biphenotypic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01887587Phase 1 · terminated Vincristine, Doxorubicin, And Dexamethasone + Ixazomib in Acute Lymphoblastic Leukemia (ALL), Lymphoblastic Lymphoma Or Mixed Phenotype Acute Leukemia · condition mapped ONTOLOGY_EXACT · 139 trials mapped (66 active) | — | — | Mixed Phenotype Acute Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00006251Phase 1/Phase 2 · completed Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine, Mycophenolate Mofetil, Donor Lymphocyte Infusion in Treating Patients With Hematopoietic Cancer · condition mapped ONTOLOGY_EXACT · 139 trials mapped (66 active) | — | — | Acute Undifferentiated Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00014235NA · completed Fludarabine Phosphate and Total-Body Radiation Followed by Donor Peripheral Blood Stem Cell Transplant and Immunosuppression in Treating Patients With Hematologic Malignancies · condition mapped ONTOLOGY_EXACT · 139 trials mapped (66 active) | — | — | Acute Undifferentiated Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02044796Phase 1/Phase 2 · completed Filgrastim, Cladribine, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With Newly Diagnosed or Relapsed/Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes · condition mapped ONTOLOGY_EXACT · 139 trials mapped (66 active) | — | — | Acute Biphenotypic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00723099Phase 2 · completed Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer · condition mapped ONTOLOGY_EXACT · 139 trials mapped (66 active) | — | — | Mixed Phenotype Acute Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03195010Phase 2 · terminated Management of Platelet Transfusion Therapy in Patients With Blood Cancer or Treatment-Induced Thrombocytopenia · condition mapped ONTOLOGY_EXACT · 139 trials mapped (66 active) | — | — | Acute Biphenotypic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02399917Phase 2 · terminated Lirilumab and Azacitidine in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 139 trials mapped (66 active) | — | — | Acute Biphenotypic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01701323Phase 1 · terminated Expanded Cord Blood Cell Infusion Following Combination Chemotherapy in Younger Patients With Relapsed or Refractory Acute Myeloid Leukemia · condition mapped CURATED_BROADER · 139 trials mapped (66 active) | — | — | Acute Leukemia of Ambiguous Lineage | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01273766Phase 2 · completed Deferasirox in Treating Iron Overload Caused By Blood Transfusions in Patients With Hematologic Malignancies · condition mapped ONTOLOGY_EXACT · 139 trials mapped (66 active) | — | — | Acute Undifferentiated Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01319864Phase 1 · completed POETIC Plerixafor as a Chemosensitizing Agent for Relapsed Acute Leukemia and MDS in Pediatric Patients · condition mapped CURATED_BROADER · 139 trials mapped (66 active) | — | — | Acute Leukemia of Ambiguous Lineage | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03599869unknown Management of Mixed-Phenotype Acute Leukemia in the East of France · condition mapped ONTOLOGY_EXACT · 139 trials mapped (66 active) | — | — | Mixed Phenotype Acute Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00898079completed Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer · condition mapped ONTOLOGY_EXACT · 139 trials mapped (66 active) | — | — | Acute Undifferentiated Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01053494NA · completed Massage Therapy Given by Caregiver in Treating Quality of Life of Young Patients Undergoing Treatment for Cancer · condition mapped ONTOLOGY_EXACT · 139 trials mapped (66 active) | — | — | Acute Undifferentiated Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01804101NA · completed Liposomal Cytarabine-Daunorubicin CPX-351 in Treating Patients With Untreated Myelodysplastic Syndrome or Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 139 trials mapped (66 active) | — | — | Acute Biphenotypic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02578511Phase 1 · withdrawn Standard Maintenance POMP/D Plus Ixazomib Maintenance Therapy in Adult Patients With Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma or Mixed Phenotype Acute Leukemia in Complete Remission (CR) · condition mapped CURATED_BROADER · 139 trials mapped (66 active) | — | — | Mixed Phenotype Acute Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00118352Phase 2 · completed Alemtuzumab, Fludarabine Phosphate, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer · condition mapped ONTOLOGY_EXACT · 139 trials mapped (66 active) | — | — | Acute Undifferentiated Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00112593NA · completed Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer · condition mapped ONTOLOGY_EXACT · 139 trials mapped (66 active) | — | — | Acute Undifferentiated Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00606216completed Structural Imaging and Cognitive Functions in Adult Stem Cell Transplant Recipients Treated With Chemotherapy Alone or in Combination With Radiotherapy · condition mapped ONTOLOGY_EXACT · 139 trials mapped (66 active) | — | — | Acute Undifferentiated Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00459212Phase 1 · completed GTI-2040 in Treating Patients With Relapsed, Refractory, or High-Risk Acute Leukemia, High-Grade Myelodysplastic Syndromes, or Refractory or Blastic Phase Chronic Myelogenous Leukemia · condition mapped ONTOLOGY_EXACT · 139 trials mapped (66 active) | — | — | Acute Undifferentiated Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01132573Phase 1 · completed Entinostat and Clofarabine in Treating Patients With Newly Diagnosed, Relapsed, or Refractory Poor-Risk Acute Lymphoblastic Leukemia or Bilineage/Biphenotypic Leukemia · condition mapped CURATED_BROADER · 139 trials mapped (66 active) | — | — | Acute Leukemia of Ambiguous Lineage | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00387426Phase 2 · terminated Sunitinib in Treating Patients With Idiopathic Myelofibrosis · condition mapped ONTOLOGY_EXACT · 139 trials mapped (66 active) | — | — | Acute Undifferentiated Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00933985Phase 1 · terminated Obatoclax Mesylate, Vincristine Sulfate, Doxorubicin Hydrochloride, and Dexrazoxane Hydrochloride in Treating Young Patients With Relapsed or Refractory Solid Tumors, Lymphoma, or Leukemia · condition mapped CURATED_BROADER · 139 trials mapped (66 active) | — | — | Acute Leukemia of Ambiguous Lineage | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01231919Phase 1 · completed MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Leukemia · condition mapped CURATED_BROADER · 139 trials mapped (66 active) | — | — | Acute Leukemia of Ambiguous Lineage | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00890747Phase 1 · completed Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy · condition mapped ONTOLOGY_EXACT · 139 trials mapped (66 active) | — | — | Acute Undifferentiated Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00079404Phase 1 · completed 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Young Patients With Relapsed or Refractory Solid Tumors or Leukemia · condition mapped ONTOLOGY_EXACT · 139 trials mapped (66 active) | — | — | Acute Undifferentiated Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00025415Phase 1 · completed Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver Dysfunction · condition mapped ONTOLOGY_EXACT · 139 trials mapped (66 active) | — | — | Acute Undifferentiated Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00098826Phase 1 · completed SB-715992 in Treating Patients With Acute Leukemia, Chronic Myelogenous Leukemia, or Advanced Myelodysplastic Syndromes · condition mapped ONTOLOGY_EXACT · 139 trials mapped (66 active) | — | — | Acute Undifferentiated Leukemia | 1 | Observed | clinicaltrials | graph → |